Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
N. Peter
Observed names:
N Peter,
NATHAN KEVIN PETER,
Peter, N.
Institution:
Barking, Havering And Redbridge University Hospitals NHS Trust
Observed institutions:
F. Hoffmann-La Roche AG,
Barking, Havering And Redbridge University Hospitals NHS Trust,
University of Cologne,
Klinikum Oldenburg,
Medizinische Universität Lausitz - Carl Thiem,
Charité – Universitätsmedizin Berlin,
Ludwig-Maximilians-Universität München,
Leipzig University
show all 8
OpenAlex ID:
A5110459853
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial
2013
·
C. Scheid
, P. Sonneveld
, et al.
·
Haematologica
·
140
PDF
Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission
2009
·
N Basara
, A Schulze
, et al.
·
Leukemia
·
89
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia
2011
·
C. Zwick
, F. Hartmann
, et al.
·
Annals of Oncology
·
44
Pegylated asparaginase in combination with high‐dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study
2003
·
O. Rosen
, H. J. Müller
, et al.
·
British Journal of Haematology
·
38
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
2017
·
S Huhn
, N Weinhold
, et al.
·
Bone Marrow Transplantation
·
36
PDF
Conventional chemoimmunotherapy (R-CHOEP-14) or high-dose therapy (R-Mega-CHOEP) for young, high-risk patients with aggressive B-cell lymphoma: Final results of the randomized Mega-CHOEP trial of the German High-Grade Non-Hodgkin Lymphona Study Group (DSHNHL).
2011
·
N. Schmitz
, M. Nickelsen
, et al.
·
Journal of Clinical Oncology
·
28
Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)
2015
·
C. Kahl
, R. Krahl
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
27
Serum levels and pharmacokinetic of rituximab in Bi-weekly R-CHOP in elderly patients with DLBCL treated in the RICOVER-60 trial:
2006
·
M. Reiser
, M. Wenger
, et al.
·
Journal of Clinical Oncology
·
14
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)
2015
·
A. Thiel
, J. Schetelig
, et al.
·
Annals of Oncology
·
13
ORAL A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours
2008
·
P. Schöffski
, A. Awada
, et al.
·
European Journal of Cancer Supplements
·
12
Serum Levels and Pharmacokinetic of Rituximab in Bi-Weekly R-CHOP in Elderly Patients with DLBCL Treated in the RICOVER-60 Trial.
2006
·
Marcel Reiser
, Michael K. Wenger
, et al.
·
Blood
·
5
High CR-Rate after Intensive Chemotherapy but Disappointing Results after Palliative Treatment in Patients with Acute Myeloid Leukemia Above the Age of 60 Years: An Analysis of the AML97#38 Study of the East German Hematology and Oncology Study Group (OSHO).
2007
·
Cornelia Becker
, R. Krahl
, et al.
·
Blood
·
2
Perceived Thermoregulation Dysfunction and Cardiovascular Symptom Burden in Patients with Metabolic Syndrome: A Multicountry Questionnaire-Based Study
2026
·
YASHAR MASHAYEKHI
, NATHAN KEVIN PETER
, et al.
·
Juntendō Igaku/Juntendo igaku
PDF
Bortezomib during induction and maintenance before and after autologous transplantation improves overall survival in patients with renal impairment: subgroup analysis from the HOVON-65/GMMG-HD4 randomized trial for newly diagnosed multiple myeloma
2011
·
Christof Scheid
, Pieter Sonneveld
, et al.
·
Bone Marrow Transplantation
[High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors].
2007
·
M May
, G Georgieva
, et al.
·
PubMed
Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.
2004
·
G. Hess
, T. Flohr
, et al.
·
Blood
Show more works
View as search
Works count:
20
Citation count:
448
H-index:
10
I10-index:
10
Year
Topic
Type